# Humacyte, Inc.: Form 8-K, filed Nov 26, 2025

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2025-11-26
- Accepted by EDGAR: Nov 26, 2025, 17:01 ET
- Period: 2025-11-21
- Accession: 0001104659-25-116476
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000110465925116476/tm2532300d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000110465925116476/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000110465925116476/tm2532300d1_8k.htm

Filed Nov 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-116476. Last ingested by Listed: Nov 11, 2026, 01:52 ET. No prices; not investment advice.